Medivation, Inc (NASDAQ:MDVN) achieved its new 52 week high price of $70.87 where it was opened at $65.10 UP 12.16 points or +21.95% by closing at $67.57. MDVN transacted shares during the day were over 3.96 million shares however it has an average volume of 602,383 shares.
Read Full Article and Disclaimer at: http://stockbling.com/9270/stock-highlights/medivation-high-momentum-nas...
Medivation, Inc (NASDAQ:MDVN) is a biopharmaceutical company focused on the rapid development of small molecule drugs to treat serious diseases, for which there are limited treatment options. Medivation, Inc achieved its new 52 week high price of $54.29 where it was opened at $49.57 UP 3.70 points or +7.54% by closing at $52.80.
Medivation, Inc at its Peak Price of the Year - NASDAQ:MDVN
Medivation, Inc (NASDAQ:MDVN) achieved its new 52 week high price of $44.93 where it was opened at $38.72 UP 1.85 points or +4.65% by closing at $41.60. MDVN transacted shares during the day were over 5.40 million shares however it has an average volume of 943,123 shares.
Read Full Article and Disclaimer at: http://crwewallstreetnewsalert.com/?p=6358
Medivation, Inc Irregular Trade during last session - NASDAQ:MDVN
Medivation, Inc showed an Odd Volume - NASDAQ:MDVN
Medivation, Inc. (NASDAQ:MDVN) witnessed volume of 2.43 million shares during last trade however it holds an average trading capacity of 541,384.00 shares. MDVN last trade opened at $17.74 reached intraday low of $17.55 and went -0.06% down to close at $17.58.
Read Full Article and Disclaimer at:http://crwewallstreetnewsalert.com/?p=6099
MDVN, ASTC, CLNO, KOOL, PRGO Stock Market Report from CRWEFinance.com
Medivation, Inc (Nasdaq:MDVN) recently announced the appointment of Cheryl Cohen as chief commercial officer. In this position, Ms. Cohen will lead the sales and marketing functions, reporting to David Hung, M.D., president and chief executive officer of Medivation.
For more information go to http://crwefinance.com/?p=20975
CSTR, CRWE, FISI, MDVN - Weekend Stock Update! by BestOTC.com
Coinstar Inc. (Nasdaq:CSTR) announced it will invest in SoloHealth, a consumer-driven healthcare technology company that develops and deploys health screening and information kiosks, including its award-winning EyeSiteÂ® product and the next-generation SoloHealth Station™. Investment details were not disclosed.